Magnesium sulfate and sodium valproate block methylphenidate-induced hyperlocomotion, an animal model of mania

Arban, 2005, Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania, Behav Brain Res, 158, 123, 10.1016/j.bbr.2004.08.015

Barbier, 2009, Anti-depressant and anxiolytic like behaviors in PKCI/HINT1 knockout mice associated with elevated plasma corticosterone level, BMC Neurosci, 10, 132, 10.1186/1471-2202-10-132

Barros, 1987, The effects of carbamazepine on two animal models of depression, Psychopharmacology (Berl), 92, 340, 10.1007/BF00210841

Beijamini, 1998, The effect of oxcarbazepine on behavioural despair and learned helplessness, Eur J Pharmacol, 347, 23, 10.1016/S0014-2999(98)00076-4

Bowden, 2002, Pharmacological treatment of bipolar disorder: a review, 5, 191

Cardoso, 2009, Evidence for the involvement of the monoaminergic system in the antide-pressant-like effect of magnesium, Prog Neuropsychopharmacol Biol Psychiatry, 33, 235, 10.1016/j.pnpbp.2008.11.007

Chouinard, 1990, A pilot study of magnesium aspartate hydrochloride (Magnesiocard) as a mood stabilizer for rapid cycling bipolar affective disorder patients, Prog Neuropsychopharmacol Biol Psychiatry, 14, 171, 10.1016/0278-5846(90)90099-3

Consoni, 2006, Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming test, Eur Neuropsychopharmacol, 16, 451, 10.1016/j.euroneuro.2006.01.003

Decollogne, 1997, NMDA receptor complex blockade by oral administration of magnesium: comparison with MK-801, Pharmacol Biochem Behav, 58, 261, 10.1016/S0091-3057(96)00555-2

Donzanti, 1984, Magnesium selectively inhibits N-methyl-aspartic acid-induced hypermotility after intra-accumbens injection, Pharmacol Biochem Behav, 20, 243, 10.1016/0091-3057(84)90249-1

Eckermann, 2001, Methylphenidate sensitization is modulated by valproate, Life Sci, 69, 47, 10.1016/S0024-3205(01)01095-5

Einat, 2006, Modeling facets of mania: new directions related to the notion of endophenotypes, J Psychopharmacol, 20, 714, 10.1177/0269881106060241

Einat, 2007, Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder, Neuropsychobiology, 55, 123, 10.1159/000106054

Euser, 2009, Magnesium sulfate for the treatment of eclampsia: a brief review, Stroke, 40, 1169, 10.1161/STROKEAHA.108.527788

Frey, 2006, Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania, Life Sci, 79, 281, 10.1016/j.lfs.2006.01.002

Giannini, 2000, Magnesium oxide augmentation of verapamil maintenance therapy in mania, Psychiatry Res, 93, 83, 10.1016/S0165-1781(99)00116-X

Gould, 2001, Differential sensitivity to lithium’s reversal of amphetamine-induced open-field activity in two inbred strains of mice, Behav Brain Res, 118, 95, 10.1016/S0166-4328(00)00318-1

Heiden, 1999, Treatment of severe mania with intravenous magnesium sulphate as a supplementary therapy, Psychiatry Res, 89, 239, 10.1016/S0165-1781(99)00107-9

Izenwasser, 1986, Stimulant-like effects of magnesium on aggression in mice, Pharmacol Biochem Behav, 25, 1195, 10.1016/0091-3057(86)90111-5

Kantak, 1990, Enhancement of apomorphine and l-amphetamine-induced behaviors by magnesium, Pharmacol Biochem Behav, 36, 29, 10.1016/0091-3057(90)90120-7

Murck, 2002, Magnesium and affective disorders, Nutr Neurosci, 5, 375, 10.1080/1028415021000039194

Nechifor, 2008, Interactions between magnesium and psychotropic drugs, Magnes Res, 21, 97

Poleszak, 2004, Antidepressant-and anxiolytic-like activity of magnesium in mice, Pharmacol Biochem Behav, 78, 7, 10.1016/j.pbb.2004.01.006

Poleszak, 2008, D-serine, a selective glycine/N-methyl-D-aspartate receptor agonist, antagonizes the antidepressant-like effects of magnesium and zinc in mice, Pharmacol Rep, 60, 996

Poleszak, 2007, NMDA/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in mice, Pharmacol Biochem Behav, 88, 158, 10.1016/j.pbb.2007.07.018

Poleszak, 2006, Immobility stress induces depression-like behavior in the forced swim test in mice: effect of magnesium and imipramine, Pharmacol Rep, 58, 746

Poleszak, 2005, Effects of acute and chronic treatment with magnesium in the forced swim test in rats, Pharmacol Rep, 57, 654

Sabioni, 2008, The antimanic-like effect of tamoxifen: behavioural comparison with other PKC-inhibiting and antiestrogenic drugs, Prog Neuropsychopharmacol Biol Psychiatry, 32, 1927, 10.1016/j.pnpbp.2008.09.023

Szabo, 2009, Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania, Neuropharmacology, 56, 47, 10.1016/j.neuropharm.2008.08.015

Szewczyk, 2008, Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action, Pharmacol Rep, 60, 588

Yang, 2001, Effects of lithium chloride on induction and expression of meth-ylphenidate sensitization, Eur J Pharmacol, 426, 65, 10.1016/S0014-2999(01)01213-4

Yildiz, 2008, Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen, Arch Gen Psychiatry, 65, 255, 10.1001/archgenpsychiatry.2007.43

Zarate, 2009, Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder, CNS Drugs, 23, 569, 10.2165/00023210-200923070-00003